Metformin and Niclosamide Synergistically Suppress Wnt and YAP in APC-Mutated Colorectal Cancer

Metformin and Niclosamide Synergistically Suppress Wnt and YAP in APC-Mutated Colorectal Cancer

The Wnt and Hippo pathways are tightly coordinated and understanding their reciprocal regulation may provide a novel therapeutic strategy for cancer. Anti-helminthic niclosamide is an effective inhibitor of Wnt and is now in a phase II trial for advanced colorectal cancer (CRC) patients. We found th...

Full description

Bibliographic Details
Main Authors:	Hee Eun Kang, Yoojeong Seo, Jun Seop Yun, Sang Hyun Song, Dawool Han, Eunae Sandra Cho, Sue Bean Cho, Yoon Jeon, Ho Lee, Hyun Sil Kim, Joyeon Kang, Jong In Yook, Nam Hee Kim, Tae Il Kim
Format:	Article
Language:	English
Published:	MDPI AG 2021-07-01
Series:	Cancers
Subjects:	colorectal cancer Wnt Hippo niclosamide metformin
Online Access:	https://www.mdpi.com/2072-6694/13/14/3437

Similar Items

Niclosamide and Pyrvinium Are Both Potential Therapeutics for Osteosarcoma, Inhibiting Wnt–Axin2–Snail Cascade
by: Young Yi, et al.
Published: (2021-09-01)

Indirect Spectrophotometric Determination of Niclosamide in Pharmaceutical Preparations
by: Nabeel S. Othman, et al.
Published: (2018-06-01)

Efficacy of niclosamide as a potential antipenetrant (TAP) against cercariae of Schistosoma mansoni monkeys
by: John I. Bruce, et al.
Published: (1992-01-01)

<b>Electrochemical oxidation of niclosamide at a glassy carbon electrode and its determination by voltammetry</b>
by: Hailemichael Alemu, et al.
Published: (2003-06-01)

Niclosamide and its derivative DK‐520 inhibit RANKL‐induced osteoclastogenesis
by: Yurui Jiao, et al.
Published: (2020-08-01)

Niclosamide inhibition of STAT3 synergizes with erlotinib in human colon cancer
by: Shi L, et al.
Published: (2017-03-01)

Hydrotalcite–Niclosamide Nanohybrid as Oral Formulation towards SARS-CoV-2 Viral Infections
by: Goeun Choi, et al.
Published: (2021-05-01)

Low doses of niclosamide and quinacrine combination yields synergistic effect in melanoma via activating autophagy-mediated p53-dependent apoptosis
by: Ding, C., et al.
Published: (2022)

Der inhibitorische Effekt von Niclosamid auf humane Pankreaskarzinom-Zelllinien und Analyse der Auswirkungen auf den Wnt- und Hedgehog-Signalweg
by: Stelling, Robin
Published: (2016)

Sensitivity of Oncomelania hupensis to Niclosamide: A Nation-Wide Survey in China
by: Jianrong Dai, et al.
Published: (2014-03-01)

Niclosamide ethanolamine ameliorates diabetes-related muscle wasting by inhibiting autophagy
by: Yuchun Cai, et al.
Published: (2021-06-01)

Long-term effect of niclosamide on inhibition of bacterial leaf blight in rice
by: Kim Sung-Il, et al.
Published: (2016-12-01)

Involvement of Up-Regulation of DR5 Expression and Down-Regulation of c-FLIP in Niclosamide-Mediated TRAIL Sensitization in Human Renal Carcinoma Caki Cells
by: Jeong Mi Yun, et al.
Published: (2018-09-01)

Binding interactions of niclosamide with serum proteins
by: Esra Maltas
Published: (2014-12-01)

Inhibition of human immunodeficiency virus type 1 by niclosamide through mTORC1 inhibition
by: Nattamon Niyomdecha, et al.
Published: (2020-06-01)

Bovine Serum Albumin-Coated Niclosamide-Zein Nanoparticles as Potential Injectable Medicine against COVID-19
by: Sanoj Rejinold N, et al.
Published: (2021-07-01)

Amorphous Solid Dispersions and the Contribution of Nanoparticles to In Vitro Dissolution and In Vivo Testing: Niclosamide as a Case Study
by: Miguel O. Jara, et al.
Published: (2021-01-01)

The molluscicidal activity of niclosamide (Bayluscide WP70®) on Melanoides tuberculata (Thiaridae), a snail associated with habitats of Biomphalaria glabrata (Planorbidae)
by: Alexandre Giovanelli, et al.
Published: (2002-07-01)

Phase II trial to investigate the safety and efficacy of orally applied niclosamide in patients with metachronous or sychronous metastases of a colorectal cancer progressing after therapy: the NIKOLO trial
by: Susen Burock, et al.
Published: (2018-03-01)

Niclosamide Triggers Non-Canonical LC3 Lipidation
by: Yajun Liu, et al.
Published: (2019-03-01)

Niclosamide Blocks Rice Leaf Blight by Inhibiting Biofilm Formation of Xanthomonas oryzae
by: Sunil Kumar Sahu, et al.
Published: (2018-03-01)

Niclosamide, an antihelmintic drug, enhances efficacy of PD-1/PD-L1 immune checkpoint blockade in non-small cell lung cancer
by: Fan Luo, et al.
Published: (2019-09-01)

Repurposing Niclosamide for Targeting Pancreatic Cancer by Inhibiting Hh/Gli Non-Canonical Axis of Gsk3β
by: Jyoti B. Kaushal, et al.
Published: (2021-06-01)

Synergistic Activity of Niclosamide in Combination With Colistin Against Colistin-Susceptible and Colistin-Resistant Acinetobacter baumannii and Klebsiella pneumoniae
by: Rafael Ayerbe-Algaba, et al.
Published: (2018-10-01)

Niclosamide–Clay Intercalate Coated with Nonionic Polymer for Enhanced Bioavailability toward COVID-19 Treatment
by: Seungjin Yu, et al.
Published: (2021-03-01)

Niclosamide loaded biodegradable chitosan nanocargoes: an in vitro study for potential application in cancer therapy
by: Saba Naqvi, et al.
Published: (2017-01-01)

Niclosamide suppresses the expansion of follicular helper T cells and alleviates disease severity in two murine models of lupus via STAT3
by: Se Gwang Jang, et al.
Published: (2021-02-01)

Drug Repurposing: The Anthelmintics Niclosamide and Nitazoxanide Are Potent TMEM16A Antagonists That Fully Bronchodilate Airways
by: Kent Miner, et al.
Published: (2019-02-01)

A Synergistic Combination of Niclosamide and Doxorubicin as an Efficacious Therapy for All Clinical Subtypes of Breast Cancer
by: Garima Lohiya, et al.
Published: (2021-06-01)

Niclosamide Exhibits Potent Anticancer Activity and Synergizes with Sorafenib in Human Renal Cell Cancer Cells
by: Xinyi Yu, et al.
Published: (2018-05-01)

Chemoprevention of Gastric Cancer: Metformin
by: Young-Il Kim, et al.
Published: (2017-12-01)

Das Antihelminthikum Niclosamid inhibiert das Wachstum kolorektaler Karzinomzelllinien durch Modulation des kanonischen und des nicht-kanonischen Wnt-Signalweges
by: Monin, Malte Benedikt
Published: (2016)

MicroRNAs Regulating Hippo-YAP Signaling in Liver Cancer
by: Na-Hyun Lee, et al.
Published: (2021-03-01)

The S100A4 Transcriptional Inhibitor Niclosamide Reduces Pro-Inflammatory and Migratory Phenotypes of Microglia: Implications for Amyotrophic Lateral Sclerosis
by: Alessia Serrano, et al.
Published: (2019-10-01)

Role of Hippo Pathway-YAP/TAZ Signaling in Angiogenesis
by: Gandhi T. K. Boopathy, et al.
Published: (2019-04-01)

Regulation of localization and function of the transcriptional co-activator YAP by angiomotin
by: Susana Moleirinho, et al.
Published: (2017-05-01)

Study on Human Taeniasis by Administring Anti-Taenia Drug
by: EB Kia, et al.
Published: (2005-09-01)

Study on Human Taeniasis by Administring Anti-Taenia Drug
by: EB Kia, et al.
Published: (2005-12-01)

Niclosamide Induces Cell Cycle Arrest in G1 Phase in Head and Neck Squamous Cell Carcinoma Through Let-7d/CDC34 Axis
by: Zewen Han, et al.
Published: (2019-01-01)

The role of Yap in lung development
by: Mahoney, John Edmund
Published: (2016)